Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index; 17 of the 22 sources its claims cite were checked for support.

Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex

Open access

Abstract

The aryl hydrocarbon receptor (AHR) possesses an extraordinary capacity to sense and respond to a wide range of small-molecule ligands, ranging from polycyclic aromatic hydrocarbons to endogenous compounds. Upon ligand binding, AHR translocates from the cytoplasm to nucleus, forming a transcriptionally active complex with aryl hydrocarbon receptor nuclear translocator (ARNT), for DNA binding and initiation of gene expression programs that include cellular detoxification pathways and immune responses. Here, we examine the molecular mechanisms governing AHR's high-affinity binding and activation by a diverse group of ligands. Crystal structures of the AHR-ARNT-DNA complexes, bound with each of six established AHR ligands, including Tapinarof, 6-formylindolo[3,2-b]carbazole (FICZ), benzo[a]pyrene (BaP), β-naphthoflavone (BNF), Indigo and Indirubin, reveal an unconventional mode of subunit assembly with intimate association between the PAS-B domains of AHR and ARNT. AHR's PAS-B domain utilizes eight conserved residues whose dynamic rearrangements account for the ability to bind to ligands through hydrophobic and π-π interactions. Our findings further reveal the structural underpinnings of a ligand-driven activation mechanism, whereby a segment of the AHR protein undergoes a structural transition from chaperone engagement to ARNT heterodimer stabilization, to generate the transcriptionally competent assembly. Our results provide key information for the future development of AHR-targeting drugs.

Overview

CoChat Summary

TL;DR

This paper reports crystal structures of AHR-ARNT-DNA complexes bound to six different AHR ligands and shows that AHR activation depends on a conserved PAS-B pocket and a conserved C-terminal loop that helps stabilize the AHR-ARNT heterodimer. The authors propose an allosteric activation mechanism in which ligand binding reorganizes AHR to promote ARNT binding, XAP2 displacement, and nuclear translocation.

Key findings

  • The authors solved AHR-ARNT-DNA crystal structures with six ligands: Tapinarof, FICZ, BaP, BNF, Indigo, and Indirubin; the Tapinarof-bound structure was at 3.0 Å, and the other ligand-bound structures ranged from 2.6 Å to 3.1 Å.
  • Across these six complexes, the overall structures were highly similar, with paired Cα RMSD values all < 0.7 Å.
  • Six ligands bind the same PAS-B pocket, but two binding modes were observed: Mode 1 for Tapinarof, FICZ, BaP, BNF, and Indigo, and Mode 2 for Indirubin.
  • Quantitative binding values by MST were reported for pAHR as 292.0 nM (Tapinarof), 444.7 nM (BaP), 1.6 μM (BNF), 1.3 μM (Indigo), and 46.6 nM (Indirubin); for hAHR as 587.0 nM, 367.0 nM, 2.2 μM, 1.8 μM, and 294.9 nM, respectively. FICZ KD could not be measured because of intrinsic fluorescence.
  • Mutational tests showed that truncating the AHR C-terminal loop decreased AHR activity at baseline and with agonists, reduced CYP1A1 expression, and that mutations such as Y330A, D329K, R398E, and H326A reduced transcriptional activity; R398E also shifted AHR toward a more cytoplasmic localization under Tapinarof.

Methods

  • Structural work combined X-ray crystallography of AHR-ARNT-DNA complexes with cryo-EM of an AHR-ARNT-DNA sample; the crystal structures used porcine AHR with human ARNT and a 21-mer dsDNA containing the 5’-TNGCGTG-3’ XRE sequence.
  • Functional validation used dual-luciferase XRE reporter assays, qPCR for CYP1A1, co-immunoprecipitation, confocal microscopy, and microscale thermophoresis in HEK293, Hep3B, HaCaT, HT1080, and HT1080 AHR-KO cells.
  • The main analyses were structural comparison, site-directed mutagenesis, RMSD comparisons, and MD/MM-GBSA-based residue contribution analysis for ligand binding.

Limitations

  • The paper states that the reported KD values should be viewed as relative indications of affinity, because the authors could not rule out preoccupation of the AHR proteins by endogenous ligands from E. coli.
  • FICZ KD could not be determined due to intrinsic fluorescence interfering with the MST signal.
  • Evident from the text: the key crystallographic complex used porcine AHR and human ARNT, and several conclusions about human AHR are inferred from sequence conservation and targeted mutants rather than a single full human AHR structure.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-025-56574-7

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Crystal structure of the AHR-ARNT heterodimer. a Schematic representation showing the domain arrangements of AHR and ARNT. bHLH, basic helix-loop-helix; PAS, PER-ARNT-SIM; TAD, transactivation domain. b The 2Fo-Fc map (contour level = 1.0 σ, shown as gray mesh) of AHR-ARNT-DNA complex structure in two views with all domains labeled. AHR, ARNT, and DNA are colored in magenta, green, and orange, respectively. c Comparison between one representative projection of 2D class averages (left) and the crystal structure of AHR-ARNT-DNA (right). The spatial locations of DNA and bHLH, PAS-A and PAS-B domains of AHR-ARNT are labeled.
Fig. 1 Crystal structure of the AHR-ARNT heterodimer. a Schematic representation showing the domain arrangements of AHR and ARNT. bHLH, basic helix-loop-helix; PAS, PER-ARNT-SIM; TAD, transactivation domain. b The 2Fo-Fc map (contour level = 1.0 σ, shown as gray mesh) of AHR-ARNT-DNA complex structure in two views with all domains labeled. AHR, ARNT, and DNA are colored in magenta, green, and orange, respectively. c Comparison between one representative projection of 2D class averages (left) and the crystal structure of AHR-ARNT-DNA (right). The spatial locations of DNA and bHLH, PAS-A and PAS-B domains of AHR-ARNT are labeled.CC BY-NC-ND · PubMed Central
Fig. 2 Potential transcriptional regulation role of AHR PAS-B C-ter loop. a Overall structure of the PAS-B domains of AHR-ARNT heterodimer. The C-ter loop of AHR PAS-B is colored in light pink. b The detailed interactions between the C-ter loop of AHR PAS-B and ARNT. The residues of AHR and ARNT are colored in magenta and green, respectively. These interactions were analyzed by the Ligplus+ program78. c Co-IP experiments showing the effect of C-ter loop deletion on the formation of AHR-ARNT heterodimers in cells. This experiment was performed three times with similar results. d, e XRE reporter assays (d) and qPCR assays (e) evaluating the effects of C-ter loop deletion on AHR transcriptional activity in HEK293 cells. f Enlarged view near the PAS-B dimer interface where H324 of AHR forms hydrogen bonds with A405 and G407 of C-ter loop. g, h XRE reporter assays (g) and qPCR assays (h) evaluating the effects of hAHR H326A mutation (corresponding to H324 in pAHR) on transactivation in HEK293 cells. For the panels d, e, g, h: error bars, mean ± s.d.; n = 3 (biological replicates); statistical significance, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (p-values shown on the charts calculated using unpaired two-tailed t test versus the WT group).
Fig. 2 Potential transcriptional regulation role of AHR PAS-B C-ter loop. a Overall structure of the PAS-B domains of AHR-ARNT heterodimer. The C-ter loop of AHR PAS-B is colored in light pink. b The detailed interactions between the C-ter loop of AHR PAS-B and ARNT. The residues of AHR and ARNT are colored in magenta and green, respectively. These interactions were analyzed by the Ligplus+ program78. c Co-IP experiments showing the effect of C-ter loop deletion on the formation of AHR-ARNT heterodimers in cells. This experiment was performed three times with similar results. d, e XRE reporter assays (d) and qPCR assays (e) evaluating the effects of C-ter loop deletion on AHR transcriptional activity in HEK293 cells. f Enlarged view near the PAS-B dimer interface where H324 of AHR forms hydrogen bonds with A405 and G407 of C-ter loop. g, h XRE reporter assays (g) and qPCR assays (h) evaluating the effects of hAHR H326A mutation (corresponding to H324 in pAHR) on transactivation in HEK293 cells. For the panels d, e, g, h: error bars, mean ± s.d.; n = 3 (biological replicates); statistical significance, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (p-values shown on the charts calculated using unpaired two-tailed t test versus the WT group).CC BY-NC-ND · PubMed Central
Fig. 3 Ligand binding characteristics of AHR PAS-B domain. a Chemical structure of AHR agonists, including Tapinarof, FICZ, BaP, BNF, Indigo, and Indirubin. b Superimposition of six AHR-ARNT-DNA complex structures respectively bound with Tapinarof, FICZ, BaP, BNF, Indigo, and Indirubin. c–h, Interactions between Tapinarof (c), FICZ (d), BaP (e), BNF (f), Indigo (g), and Indirubin (h) with surrounding AHR residues within the pocket, analyzed by the Ligplus+ program78. i A summarized diagram showing the residues of the AHR PAS-B domain directly interacting with each of the six ligands. Residues forming hydrophobic and van der Waals interactions are colored in green, and those forming hydrogen bonds are colored in magenta. j The spatial distribution of eight AHR residues involved in direct interactions with all six ligands are shown in two views.
Fig. 3 Ligand binding characteristics of AHR PAS-B domain. a Chemical structure of AHR agonists, including Tapinarof, FICZ, BaP, BNF, Indigo, and Indirubin. b Superimposition of six AHR-ARNT-DNA complex structures respectively bound with Tapinarof, FICZ, BaP, BNF, Indigo, and Indirubin. c–h, Interactions between Tapinarof (c), FICZ (d), BaP (e), BNF (f), Indigo (g), and Indirubin (h) with surrounding AHR residues within the pocket, analyzed by the Ligplus+ program78. i A summarized diagram showing the residues of the AHR PAS-B domain directly interacting with each of the six ligands. Residues forming hydrophobic and van der Waals interactions are colored in green, and those forming hydrogen bonds are colored in magenta. j The spatial distribution of eight AHR residues involved in direct interactions with all six ligands are shown in two views.CC BY-NC-ND · PubMed Central
Fig. 4 Ligand-specific binding and activation of AHR. a Superimposition of AHR PAS-B domain structures bound by FICZ (purple) or Indirubin (magenta). The binding modes of FICZ and Indirubin in the pocket are represented by arrows. b XRE reporter assays evaluating the effects of hAHR Y332A mutation (corresponding to Y330 in pAHR) on transactivation. c, d The apparent dissociation constants of Tapinarof, BaP, BNF, Indigo, and Indirubin to pAHR (c) and hAHR (d) as determined by the MST method from three technical replicates at each compound concentration. e, f XRE reporter assays evaluating the dose-responsive activation of AHR by six agonists in Hep3B (e) and HaCaT (f) cells. For Panels b,e,f: error bars, mean ± s.d.; n = 3 (biological replicates); statistical significance: ** p < 0.01, *** p < 0.001 (p-values shown on the charts calculated using unpaired two-tailed t test versus the WT group).
Fig. 4 Ligand-specific binding and activation of AHR. a Superimposition of AHR PAS-B domain structures bound by FICZ (purple) or Indirubin (magenta). The binding modes of FICZ and Indirubin in the pocket are represented by arrows. b XRE reporter assays evaluating the effects of hAHR Y332A mutation (corresponding to Y330 in pAHR) on transactivation. c, d The apparent dissociation constants of Tapinarof, BaP, BNF, Indigo, and Indirubin to pAHR (c) and hAHR (d) as determined by the MST method from three technical replicates at each compound concentration. e, f XRE reporter assays evaluating the dose-responsive activation of AHR by six agonists in Hep3B (e) and HaCaT (f) cells. For Panels b,e,f: error bars, mean ± s.d.; n = 3 (biological replicates); statistical significance: ** p < 0.01, *** p < 0.001 (p-values shown on the charts calculated using unpaired two-tailed t test versus the WT group).CC BY-NC-ND · PubMed Central
Fig. 5 Conformational changes of the C-ter loop of AHR PAS-B domain from cytosol to nucleus. a Superimposition of the AHR PAS-B domain structures from heterodimeric pAHR in complex with Indirubin (light blue), chaperoned hAHR with Indirubin (marine blue), and chaperoned mAHR with no ligand (cyan) in two views. b Superimposition of the AHR PAS-B domain structures from heterodimeric pAHR with Indirubin (light blue) and chaperoned mAHR with no ligand (cyan). Residues D327/D323 in Fα, F349/F345 and V348/V344 in Gβ, and R396/R392 in Jα are shown as sticks. c XRE reporter assay evaluating the effects of hAHR R398E mutation (corresponding to R396 in pAHR) and hAHR D329K mutation (corresponding to D327 in pAHR) on transactivation (n = 3 biological replicates). d Representative confocal fluorescence microscopy images of cells expressing wild-type (WT) or R398E mutant of hAHR-GFP proteins in the presence of 50 nM Tapinarof (left) and calculated ratio of cytoplasmic: nuclear fluorescence ratio (right). Scale bar = 50 μm. This experiment was performed three times with similar results (n = 20 biological replicates). For the panels c, d: error bars, mean ± s.d.; statistical significance, **** p < 0.0001 (p-values shown on the charts calculated using unpaired two-tailed t test versus the WT group).
Fig. 5 Conformational changes of the C-ter loop of AHR PAS-B domain from cytosol to nucleus. a Superimposition of the AHR PAS-B domain structures from heterodimeric pAHR in complex with Indirubin (light blue), chaperoned hAHR with Indirubin (marine blue), and chaperoned mAHR with no ligand (cyan) in two views. b Superimposition of the AHR PAS-B domain structures from heterodimeric pAHR with Indirubin (light blue) and chaperoned mAHR with no ligand (cyan). Residues D327/D323 in Fα, F349/F345 and V348/V344 in Gβ, and R396/R392 in Jα are shown as sticks. c XRE reporter assay evaluating the effects of hAHR R398E mutation (corresponding to R396 in pAHR) and hAHR D329K mutation (corresponding to D327 in pAHR) on transactivation (n = 3 biological replicates). d Representative confocal fluorescence microscopy images of cells expressing wild-type (WT) or R398E mutant of hAHR-GFP proteins in the presence of 50 nM Tapinarof (left) and calculated ratio of cytoplasmic: nuclear fluorescence ratio (right). Scale bar = 50 μm. This experiment was performed three times with similar results (n = 20 biological replicates). For the panels c, d: error bars, mean ± s.d.; statistical significance, **** p < 0.0001 (p-values shown on the charts calculated using unpaired two-tailed t test versus the WT group).CC BY-NC-ND · PubMed Central
Fig. 6 Conformational changes and protein-protein interactions of AHR during its transition from cytosolic status to heterodimeric form in nucleus. a Structural superimposition of AHR PAS-B domains in the heterodimeric and cytosolic/chaperoned complexes. No steric hindrance apparently exists between the ARNT PAS-B domain and HSP90 or XAP2. b Co-IP experiments showing interactions between XAP2 and the AHR-ARNT heterodimer in the presence or absence of 1 μM Tapinarof. This experiment was performed three times with similar results. c Multi-step mechanism of AHR transformation. In the cytosol, ligand binding to AHR may weaken the interactions between the AHR PAS-B C-ter loop and XAP2. In the nucleus, ARNT binding to AHR (likely via their bHLH and PAS-A domains at the beginning) may result in the formation of a transient HSP90-XAP2-P23-AHR-ARNT complex. P23 and XAP2 may subsequently leave this complex, as the interactions between PAS-B domains of AHR and ARNT eventually lead to the complete formation of the heterodimer. Two HSP90 proteins are colored in blue; two P23 proteins are colored in yellow; XAP2, AHR, and ARNT are colored in brown, magenta, and green, respectively.
Fig. 6 Conformational changes and protein-protein interactions of AHR during its transition from cytosolic status to heterodimeric form in nucleus. a Structural superimposition of AHR PAS-B domains in the heterodimeric and cytosolic/chaperoned complexes. No steric hindrance apparently exists between the ARNT PAS-B domain and HSP90 or XAP2. b Co-IP experiments showing interactions between XAP2 and the AHR-ARNT heterodimer in the presence or absence of 1 μM Tapinarof. This experiment was performed three times with similar results. c Multi-step mechanism of AHR transformation. In the cytosol, ligand binding to AHR may weaken the interactions between the AHR PAS-B C-ter loop and XAP2. In the nucleus, ARNT binding to AHR (likely via their bHLH and PAS-A domains at the beginning) may result in the formation of a transient HSP90-XAP2-P23-AHR-ARNT complex. P23 and XAP2 may subsequently leave this complex, as the interactions between PAS-B domains of AHR and ARNT eventually lead to the complete formation of the heterodimer. Two HSP90 proteins are colored in blue; two P23 proteins are colored in yellow; XAP2, AHR, and ARNT are colored in brown, magenta, and green, respectively.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

13 Valid · 0 Not valid · 4 Not checked · 92 Own results and interpretations

72 more claims · 2 with their cited sources checked

Create a free account to see all 109 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 23

Create a free account to see these claims.

Citations

Cites

Show all 80 references

Cited by

See all 72

Metadata

Authors
Diao, X., Shang, Q., Guo, M., Huang, Y., Zhang, M., Chen, X., Liang, Y., Sun, X., Zhou, F., Zhuang, J., Liu, S.-J., Vogel, C. F. A., Rastinejad, F., & Wu, D.
Affiliations
  • Shandong University (CN)
  • University of California, Davis (US)
  • University of Oxford (GB)
Corresponding author
Wu, Dalei
Venue
Nature communications
Published
2025-02-03
Volume
16
Issue
1
Pages
1282-1282
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4407083612
Cited by
72
References
80
Citations by year
2026: 54 · 2025: 18
FWCI
30.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (82373876, 22177063)
  • National Key R&D Program of China
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
aryl hydrocarbon receptor, ARNT, ligand-dependent activation, PAS-B domain, protein-DNA complex crystal structure, tapinarof, FICZ, benzo[a]pyrene, beta-naphthoflavone, indigo, indirubin, π-π stacking, hydrophobic interactions, transcriptional activation
MeSH terms
Benzo(a)pyrene, Carbazoles, DNA, Humans, Indoles, Ligands, Models, Molecular, Protein Binding, Receptors, Aryl Hydrocarbon, Crystallography, X-Ray, beta-Naphthoflavone, Aryl Hydrocarbon Receptor Nuclear Translocator, Basic Helix-Loop-Helix Proteins, Protein Multimerization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex. https://app.cochat.ai/papers/10.1038/s41467-025-56574-7
The paper
Diao, X., Shang, Q., Guo, M., Huang, Y., Zhang, M., Chen, X., Liang, Y., Sun, X., Zhou, F., Zhuang, J., Liu, S.-J., Vogel, C. F. A., Rastinejad, F., & Wu, D. (2025). Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex. Nature communications. https://doi.org/10.1038/s41467-025-56574-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.